Clinics in Liver Disease

Scope & Guideline

Fostering knowledge and innovation in liver disease research.

Introduction

Delve into the academic richness of Clinics in Liver Disease with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1089-3261
PublisherW B SAUNDERS CO-ELSEVIER INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1997 to 2024
AbbreviationCLIN LIVER DIS / Clin. Liver Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899

Aims and Scopes

The journal 'Clinics in Liver Disease' aims to provide comprehensive insights and advances in the field of liver disease management, focusing on a wide range of topics including pathophysiology, diagnosis, treatment, and complications associated with liver disorders. The journal emphasizes evidence-based practices and innovative methodologies to enhance clinical care and research in hepatology.
  1. Portal Hypertension:
    The journal covers extensive research on portal hypertension, including its pathophysiology, complications, management strategies, and surgical interventions.
  2. Hepatic Encephalopathy:
    A significant focus on hepatic encephalopathy is evident, exploring its clinical manifestations, management strategies, and the socio-economic burden it imposes on healthcare systems.
  3. Autoimmune Liver Diseases:
    The journal addresses various autoimmune liver diseases such as autoimmune hepatitis and primary biliary cholangitis, focusing on their pathophysiology, diagnosis, and treatment options.
  4. Chronic Viral Hepatitis:
    Research on chronic viral hepatitis, particularly hepatitis B and C, is a core area, highlighting new therapies, epidemiology, and management challenges.
  5. Nonalcoholic Fatty Liver Disease (NAFLD):
    The journal discusses NAFLD extensively, including its epidemiology, pathogenesis, and the impact of associated conditions such as metabolic syndrome.
  6. Liver Transplantation:
    The scope includes discussions on liver transplantation, donor selection, complications, and post-transplant management, reflecting its critical role in hepatology.
  7. Acute-on-Chronic Liver Failure:
    Research on acute-on-chronic liver failure is prominent, examining its clinical spectrum, management challenges, and therapeutic innovations.
  8. Endoscopic and Interventional Procedures:
    The journal includes studies on endoscopic and interventional radiology techniques for managing liver diseases, emphasizing minimally invasive approaches.
The journal is currently witnessing a trend towards several emerging themes that reflect the evolving landscape of liver disease research and clinical practice. These themes indicate areas of growing interest and significance within the field.
  1. Noninvasive Assessment Techniques:
    There is a growing emphasis on noninvasive assessment methods for liver diseases, particularly in evaluating fibrosis and portal hypertension, as they offer safer alternatives to traditional methods.
  2. Integrated Management of Hepatic Encephalopathy:
    Increased focus on integrated management strategies for hepatic encephalopathy highlights the need for comprehensive care that addresses not only clinical symptoms but also social and economic factors.
  3. Innovative Therapies for Autoimmune Liver Diseases:
    Research into novel therapies for autoimmune liver diseases is on the rise, reflecting advancements in treatment options and a better understanding of disease mechanisms.
  4. Genetic and Metabolic Factors in Liver Disease:
    Emerging research is focusing on the genetic and metabolic underpinnings of liver diseases, particularly in relation to NAFLD and its systemic implications.
  5. Portal Hypertension Complications:
    A significant increase in studies addressing the various complications associated with portal hypertension indicates an expanding understanding and management of this complex condition.

Declining or Waning

While 'Clinics in Liver Disease' maintains a broad focus, certain themes appear to be declining in prominence, reflecting shifts in research priorities and clinical practice. The following areas have seen reduced coverage in recent publications.
  1. Traditional Hepatitis Management:
    There has been a noticeable decline in papers focusing on traditional management strategies for hepatitis, as newer, more effective treatments and approaches are being developed and adopted.
  2. Alcoholic Liver Disease Research:
    Although still relevant, the volume of research specifically addressing alcoholic liver disease has decreased, possibly due to a shift towards more comprehensive metabolic liver disease studies.
  3. Chronic Kidney Disease in Liver Disease:
    Research specifically linking chronic kidney disease with liver disease has waned, likely as more attention is directed toward integrated approaches that encompass broader aspects of liver health.
  4. Liver Biopsy Techniques:
    The frequency of papers discussing liver biopsy techniques has decreased, likely due to the increasing reliance on noninvasive diagnostic methods.
  5. Emerging Biomarkers in Liver Disease:
    Research on emerging biomarkers for liver disease diagnosis and prognosis has seen a decline, possibly overshadowed by advancements in imaging and noninvasive testing.

Similar Journals

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Advancing the Frontiers of Gastrointestinal and Liver Research
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0193-1857Frequency: 12 issues/year

American Journal of Physiology-Gastrointestinal and Liver Physiology, published by the American Physiological Society, stands as a leading journal in the domains of gastroenterology, hepatology, and overall physiology. With an impressive impact factor and consistent ranking in the Q1 quartile across multiple categories, this journal provides a vital platform for disseminating advanced research and innovative findings related to gastrointestinal and liver physiology. Since its inception in 1980, the journal has fostered a community of researchers and clinicians dedicated to understanding and improving digestive and liver health. While maintaining a traditional subscription model, it ensures high-quality peer-reviewed content that is crucial for informed professional practice and academic inquiry. The journal’s Scopus ranks highlight its significant impact in the fields of gastroenterology and hepatology, making it an indispensable resource for academics and practitioners alike, eagerly exploring both foundational and cutting-edge topics in physiology.

Journal of Gastrointestinal and Liver Diseases

Unveiling the Latest in Gastrointestinal and Liver Diseases
Publisher: MEDICAL UNIV PRESSISSN: 1841-8724Frequency: 4 issues/year

The Journal of Gastrointestinal and Liver Diseases, published by MEDICAL UNIV PRESS in Romania, serves as a pivotal platform for the dissemination of significant research in the fields of gastroenterology and hepatology. Established in 2006, this journal has evolved over the years, currently holding a Q3 rank in Gastroenterology and a Q2 rank in Medicine (miscellaneous), reflecting its commitment to high-quality scholarship and impactful contributions to medical science.

With an ISSN of 1841-8724 and an E-ISSN of 1842-1121, the journal engages a diverse readership of researchers, clinicians, and students passionate about advancing knowledge in gastrointestinal and liver health. While it currently does not operate under an open access model, the journal remains a vital resource for those seeking to stay updated on the latest developments and emerging trends in the field. As it converges towards a broader impact, projected through its coverage until 2024, the Journal of Gastrointestinal and Liver Diseases continues to contribute to the academic landscape, encouraging innovation and comprehensive understanding in digestive health.

Hepatology International

Connecting experts to revolutionize liver health.
Publisher: SPRINGERISSN: 1936-0533Frequency: 4 issues/year

Hepatology International is a premier academic journal dedicated to advancing the field of liver research and hepatology. Published by SPRINGER, this journal boasts a prestigious Q1 ranking in Hepatology as of 2023, underscoring its commitment to high-quality research dissemination. The journal’s scope encompasses a wide range of topics related to liver disease, including clinical, translational, and basic science studies. With its impact factor reflecting its relevance and influence in the field, Hepatology International serves as an essential resource for researchers, clinicians, and students aiming to keep abreast of the latest developments and breakthroughs. Though traditionally a subscription-based journal, it offers a vast array of insightful articles that contribute significantly to our understanding of hepatological conditions. The journal continues its trajectory of growth since its inception in 2008, anticipating a convergence of knowledge and innovation through to 2024. Located in the heart of New York City, this journal not only represents a crucial platform for global hepatology research but also fosters a collaborative community of experts dedicated to improving liver health worldwide.

LIVER INTERNATIONAL

Elevating the standards of liver research globally.
Publisher: WILEYISSN: 1478-3223Frequency: 12 issues/year

LIVER INTERNATIONAL, with its ISSN 1478-3223 and E-ISSN 1478-3231, is a prestigious peer-reviewed journal published by Wiley in the United Kingdom. Established in 2003, it focuses on advancing the field of hepatology, covering a broad spectrum of topics including liver disease, hepatocellular carcinoma, and transplantation. Ranking #10 out of 82 in the Scopus category for Medicine - Hepatology and boasting a remarkable 88th percentile, LIVER INTERNATIONAL has secured its reputation as a leading journal, recognized as Q1 in the 2023 category quartiles. The journal emphasizes accessibility, offering an open access option to ensure that critical research findings reach a wider audience. By facilitating the dissemination of high-quality research, LIVER INTERNATIONAL plays a vital role in shaping contemporary hepatological discourse and bridging academic inquiry with clinical practice, making it an essential resource for researchers, healthcare professionals, and students alike.

Clinical Gastroenterology and Hepatology

Advancing the Frontiers of Gastroenterology and Hepatology
Publisher: ELSEVIER SCIENCE INCISSN: 1542-3565Frequency: 12 issues/year

Clinical Gastroenterology and Hepatology, published by Elsevier Science Inc, stands as a leading journal in the fields of gastroenterology and hepatology. With an ISSN of 1542-3565 and an E-ISSN of 1542-7714, this esteemed publication has earned its place in the top quartile (Q1) of both gastroenterology and hepatology categories as of 2023, ranking 6th out of 167 and 7th out of 82 respectively. The journal aims to disseminate innovative research, clinical studies, and case reports that advance the understanding and treatment of gastrointestinal and liver diseases. Targeted towards researchers, healthcare professionals, and students, it provides crucial insights into emerging therapies and medical advancements. Clinical Gastroenterology and Hepatology is not only a pivotal resource for contemporary gastroenterological research but also fosters collaboration and knowledge-sharing within the medical community. With a converging publication history from 2003 to the present, the journal continues to build on its solid foundation of scientific excellence and relevance.

Canadian Liver Journal

Leading the Charge Against Liver Diseases.
Publisher: UNIV TORONTO PRESS INCISSN: Frequency: 4 issues/year

Canadian Liver Journal, published by University of Toronto Press Inc., offers a dedicated platform for the dissemination of cutting-edge research in the field of Hepatology. With an E-ISSN of 2561-4444, this journal plays a pivotal role in advancing knowledge related to liver diseases and therapies, currently ranked in the 3rd quartile (Q3) for the 2023 category in Hepatology—a reflection of its growing influence in the biomedical research community. The journal, which has been in circulation since 2018 and sets its sights on contributing valuable insights until 2024, aims to engage researchers, clinicians, and students alike by providing a rigorous peer-reviewed environment for sharing findings, case studies, and reviews pertinent to liver health. Through its commitment to excellence and scholarly impact, the Canadian Liver Journal serves as an essential resource for those dedicated to combating liver diseases and enhancing patient care.

Korean Journal of Gastroenterology

Championing Breakthroughs in Gastroenterology
Publisher: Korean Soc GastroenterologyISSN: 1598-9992Frequency: 12 issues/year

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

JHEP Reports

Unlocking innovations in gastroenterology and beyond.
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

JHEP Reports, published by ELSEVIER, stands at the forefront of scholarly communication in the fields of Gastroenterology, Hepatology, Immunology and Allergy, and Internal Medicine. As an Open Access journal since 2019, it provides a platform for the dissemination of high-quality research findings, making vital information readily accessible to a global audience. With a commendable impact characterized by a Q1 category ranking across four medical disciplines in 2023, JHEP Reports demonstrates its significance and influence, reflected in its impressive Scopus ranks—#11 in Gastroenterology and #14 in Internal Medicine, amongst others. This esteemed journal not only plays a critical role in advancing knowledge but also fosters collaboration among researchers, practitioners, and students keen on exploring innovations and breakthroughs in health sciences. At RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, JHEP Reports is committed to bridging the gap between research and application, ushering in a new era of informed and effective healthcare solutions.

Translational Gastroenterology and Hepatology

Transforming Laboratory Insights into Clinical Excellence.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Transforming understanding of gastroenterology and hepatology.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.